ArticleFrontiers in public health2025
"Wing leaders" in recovery residences: staff key approaches supporting criminal legal system-involved residents receiving medication for opioid use disorder.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Introduction: Recovery homes (also known as recovery residences or sober living homes) are an effective approach to addressing substance use disorder in the United States and have been classified into four levels of care by the National Association of Recovery Residences (NARR). These homes may be particularly successful in supporting recovery and reintegration for individuals in the criminal legal system (CLS) through increased stability and better employment outcomes, reduced recidivism, and bolstered confidence in remaining substance-free. Despite promising findings, more research across the different recovery residence levels is needed to identify the key elements that contribute to their success. This paper focuses on essential factors identified by staff working at residences which fit within NARR Level 3 for effectively supporting CLS individuals receiving medication for opioid use disorder (MOUD). Methods: As part of a larger qualitative project of recovery homes most aligned with NARR Level 3, focus groups were conducted with 19 staff members in Chicago-area recovery homes (n = 4) that serve CLS residents receiving MOUD. MAXQDA software was used to organize and analyze data. Results: As described by staff, effective support for CLS-involved residents receiving MOUD centers on two recovery goals: (1) promoting sobriety and (2) fostering personal and social stability. To encourage sobriety, recovery home staff address essential needs such as medical care, mental health support, and acquiring identity documents. These homes also waive monthly fees or what most home operators call sustainability fees (room and board). Staff also enforce strict rules and ensure active engagement with program expectations. To support personal and social stability, program content is delivered by staff with significant lived experience in both CLS and substance use. Discussion: Through programming, staff provide skills-based education to guide residents toward gradual independence aimed at destigmatizing CLS-involved residents and assisting in reintegration. However, the effectiveness of this support may be limited for those receiving MOUD as staff in this study did not actively encourage discussions about MOUD in recovery. This omission potentially reinforces stigma and hinders authentic relationships required for the social model of recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.